Issue 4 2024
-
Session to Provide Update on CNS Angiitis in Children
Eyal Muscal, MD, MS, will review clinical features and novel biomarkers of pediatric primary angiitis of the central nervous system in a session that will explore the diagnostic schema and treatment regimens that can support clinicians in recognizing and treating the disease more efficiently.
-
Pioneer in B-Cell Function and Therapeutic Targeting in Autoimmune Disease Will Share Cutting-Edge Research on RA Synovitis
Jennifer Anolik, MD, PhD, will discuss the latest findings on rheumatoid arthritis pathogenesis and progression obtained via detailed characterization of patient-derived synovial tissue samples in this State-of-the-Art lecture.
-
International Panel Will Detail How Multidisciplinary Strategies for Navigating OA Differ Across the Globe
Osteoarthritis is the most widespread form of rheumatic disease without a cure. Experts from North America and Europe, including Rikke Helene Moe, PhD, of Norway, will discuss the interprofessional approaches used in different countries to care for patients living with the disease.
-
Session to Detail How the Patient Perspective Can Transform Rheumatology Care and Research
Experts, including patient advocate Eileen Davidson, will explain how the patient’s perspective is fundamental to making advances in the field, whether it’s understanding practical issues that patients grapple with daily or providing a different interpretation of data.
-
Former ARP Presidents Analyze Successes and Challenges of the Past to Build for the Future
Donning small plastic sprouts symbolizing optimism and a spirit of growth, former ARP presidents, including Teresa Brady, PhD, MACR, led a session highlighting achievements among rheumatology professionals and within the ARP over the past 35 years as a way of putting into perspective the current…
-
FDA Gives Updates on Newly Approved Agents for Rheumatic Diseases
The U.S. Food and Drug Administration approved indications for adult and pediatric rheumatology as well as new biosimilars and interchangeables for the treatment of rheumatic disease. Erick J. Gapud, MD, PhD, provided an overview of these drugs.
-
Clinicians Discuss Experience Using Ambient Listening Technology in Clinical Practice
Michael Pfeffer, MD, FACP, discussed his experience piloting technology that utilizes artificial intelligence to listen to real-time conversations between healthcare providers and patients, transcribing the dialogue into text that can become a patient note.
-
Speakers Explain How to Use Performance Measures for Hip, Knee OA Research and Care
Performance-based tests and patient-reported outcome measures should be used in conjunction for the most comprehensive assessment of patient function and changes in function over time. Experts including Christine A. Pellegrini, PhD, discussed the advantages and shortcoming of these tools.
-
Session to Highlight Emerging Pathways in Immune-Induced Exaggerated Pain
Dana Orange, MD, will discuss the disconnect she has observed between the level of pain and the amount of inflammation seen in the joints of patients with rheumatoid arthritis. Additional topics include calcium signaling in neuropathic pain and novel peptide Kv1.3 channel blockers.
-
Pediatric Rheumatology Meets Friendly Competition with Game-Based Learning
New to the ACR Convergence lineup, the online game platform Kahoot! will challenge attendees’ knowledge of caring for young patients with rheumatic disease. The trivia-style competition will take place in real time during the session and requires a device that can connect to the internet.